These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
515 related articles for article (PubMed ID: 19325493)
1. Biomarkers in prostate cancer diagnosis and prognosis: beyond prostate-specific antigen. Fradet Y Curr Opin Urol; 2009 May; 19(3):243-6. PubMed ID: 19325493 [TBL] [Abstract][Full Text] [Related]
2. Prognostic value of serum markers for prostate cancer. Stenman UH; Abrahamsson PA; Aus G; Lilja H; Bangma C; Hamdy FC; Boccon-Gibod L; Ekman P Scand J Urol Nephrol Suppl; 2005 May; (216):64-81. PubMed ID: 16019759 [TBL] [Abstract][Full Text] [Related]
3. New molecular biomarkers for the prognosis and management of prostate cancer--the post PSA era. Bickers B; Aukim-Hastie C Anticancer Res; 2009 Aug; 29(8):3289-98. PubMed ID: 19661347 [TBL] [Abstract][Full Text] [Related]
4. UPM3: review of a new molecular diagnostic urine test for prostate cancer. Saad F Can J Urol; 2005 Feb; 12 Suppl 1():40-3; discussion 99-100. PubMed ID: 15780164 [TBL] [Abstract][Full Text] [Related]
5. Contemporary role of prostate cancer antigen 3 in the management of prostate cancer. Auprich M; Bjartell A; Chun FK; de la Taille A; Freedland SJ; Haese A; Schalken J; Stenzl A; Tombal B; van der Poel H Eur Urol; 2011 Nov; 60(5):1045-54. PubMed ID: 21871709 [TBL] [Abstract][Full Text] [Related]
6. Biomarkers for prostate cancer detection. Reed AB; Parekh DJ Expert Rev Anticancer Ther; 2010 Jan; 10(1):103-14. PubMed ID: 20014890 [TBL] [Abstract][Full Text] [Related]
7. Beyond PSA: utility of novel tumor markers in the setting of elevated PSA. Lin DW Urol Oncol; 2009; 27(3):315-21. PubMed ID: 19414121 [TBL] [Abstract][Full Text] [Related]
8. Contemporary role of prostate cancer gene 3 in the management of prostate cancer. Roobol MJ Curr Opin Urol; 2011 May; 21(3):225-9. PubMed ID: 21301341 [TBL] [Abstract][Full Text] [Related]
9. [Biomarkers for prostate cancer in predicting diagnosis, staging and prognosis]. Ohori M Gan To Kagaku Ryoho; 2009 Jan; 36(1):6-10. PubMed ID: 19151558 [TBL] [Abstract][Full Text] [Related]
10. Serum markers for prostate cancer: a rational approach to the literature. Steuber T; O'Brien MF; Lilja H Eur Urol; 2008 Jul; 54(1):31-40. PubMed ID: 18243505 [TBL] [Abstract][Full Text] [Related]
11. The usefulness of the detection of GSTP1 methylation in urine as a biomarker in the diagnosis of prostate cancer. Woodson K; O'Reilly KJ; Hanson JC; Nelson D; Walk EL; Tangrea JA J Urol; 2008 Feb; 179(2):508-11; discussion 511-2. PubMed ID: 18076912 [TBL] [Abstract][Full Text] [Related]
12. PCA3: from basic molecular science to the clinical lab. Day JR; Jost M; Reynolds MA; Groskopf J; Rittenhouse H Cancer Lett; 2011 Feb; 301(1):1-6. PubMed ID: 21093148 [TBL] [Abstract][Full Text] [Related]
13. [Markers for diagnosis, prediction and prognosis of prostate cancer]. Taskén KA; Angelsen A; Svindland A; Eide T; Berge V; Wahlquist R; Karlsen S Tidsskr Nor Laegeforen; 2005 Dec; 125(23):3279-82. PubMed ID: 16327854 [TBL] [Abstract][Full Text] [Related]
14. New circulating biomarkers for prostate cancer. Bensalah K; Lotan Y; Karam JA; Shariat SF Prostate Cancer Prostatic Dis; 2008; 11(2):112-20. PubMed ID: 17998918 [TBL] [Abstract][Full Text] [Related]
15. Urine markers in monitoring for prostate cancer. Jamaspishvili T; Kral M; Khomeriki I; Student V; Kolar Z; Bouchal J Prostate Cancer Prostatic Dis; 2010 Mar; 13(1):12-9. PubMed ID: 19652665 [TBL] [Abstract][Full Text] [Related]
16. Other biomarkers for detecting prostate cancer. Nogueira L; Corradi R; Eastham JA BJU Int; 2010 Jan; 105(2):166-9. PubMed ID: 19930175 [TBL] [Abstract][Full Text] [Related]
17. Risk of developing prostate cancer in the future: overview of prognostic biomarkers. Fleshner NE; Lawrentschuk N Urology; 2009 May; 73(5 Suppl):S21-7. PubMed ID: 19375623 [TBL] [Abstract][Full Text] [Related]
18. Prostate-specific antigen kinetics in localized and advanced prostate cancer. Fitzpatrick JM; Banu E; Oudard S BJU Int; 2009 Mar; 103(5):578-87. PubMed ID: 19210674 [TBL] [Abstract][Full Text] [Related]
19. Detection of TMPRSS2-ERG fusion transcripts and prostate cancer antigen 3 in urinary sediments may improve diagnosis of prostate cancer. Hessels D; Smit FP; Verhaegh GW; Witjes JA; Cornel EB; Schalken JA Clin Cancer Res; 2007 Sep; 13(17):5103-8. PubMed ID: 17785564 [TBL] [Abstract][Full Text] [Related]
20. Molecular markers of prostate cancer. Bradford TJ; Tomlins SA; Wang X; Chinnaiyan AM Urol Oncol; 2006; 24(6):538-51. PubMed ID: 17138135 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]